Model ‐based assessment of the benefits and risks of recombinant tissue plasminogen activator treatment in acute ischaemic stroke

British Journal of Clinical Pharmacology,Volume 0, Issue ja, -Not available-.

Source: British Journal of Clinical Pharmacology - July 13, 2018 Category: Drugs & Pharmacology Authors: JinjuGuk , DongwooChae , HankilSon , JoonsangYoo , Ji HoeHeo , KyungsooPark Source Type: research